We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » MEDICARE REIMBURSEMENT PRESENTS NEW TIGHTROPE WALK FOR DRUGMAKERS
MEDICARE REIMBURSEMENT PRESENTS NEW TIGHTROPE WALK FOR DRUGMAKERS
January 23, 2004
Over the next two years, drugmakers will have to finesse the way they handle price breaks for large-volume purchasers in order to have those prices excluded from future reimbursement averages determined by legislators under the new Medicare Rx drug law.